Navigation Links
Roche Diagnostics Opens State-of-the-Art Training Center in California
Date:12/7/2009

INDIANAPOLIS, Dec. 7 /PRNewswire/ -- Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and east coasts. Roche has an existing training center at its headquarters in Indianapolis and is planning to open an additional facility in New Jersey in 2010.

The expansion of training centers beyond Indianapolis is intended to support Roche's goal of offering customers best-in-class service, according to Michael Tillmann, president and CEO of Roche Diagnostics North America. "Hands-on training with our products can enhance the learning experience for our customers and help them translate that knowledge into greater efficiencies and better outcomes in their own labs," he said. "Adding advanced training facilities on the west and east coasts will make it much easier for customers to access the training and accommodate the travel into their schedules."

The new Pleasanton training center, which includes three classrooms and a working laboratory, occupies approximately 5,000 square feet at an existing facility owned by Roche Molecular Systems, a division of Roche Diagnostics. The center will house the latest Roche instrumentation used for molecular diagnostics and clinical chemistry/immunochemistry testing, and will be managed by Roche's Indianapolis-based training team, which coordinates training for all U.S. customers.

"Having these new facilities will not only make it easier to provide our existing customers with training, it will also enable more potential customers to see our diagnostics solutions in operation," said Marco Casarin, Senior Vice President, Roche Services North America. "We also intend to use the centers to facilitate user group meetings, where customers can share best practices and see the potential for what they could achieve with their labs."

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:



Betsy Cox
Director, Corporate Communications
Roche Diagnostics Corporation
Indianapolis, IN
(317) 521-7252
betsy.cox@roche.com


SOURCE Roche Diagnostics


'/>"/>
SOURCE Roche Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... BEACH, Va. , Feb. 21, 2017  Global ... now covers Dermacell ® for breast ... foot ulcers. Dermacell is an advanced acellular dermal matrix ... Technologies, Inc. (NASDAQ: NVDQ ) ... the four major commercial health-care payers to review the ...
(Date:2/21/2017)... 2017   BeyondSpring Pharmaceuticals , a clinical ... innovative immuno-oncology cancer therapies, today announced that the ... Phase 2 trial of BeyondSpring,s innovative lead asset, ... cell lung cancer (NSCLC) with Docetaxel has been ... Clinical Immuno-Oncology Symposium in Orlando, Fla. ...
(Date:2/21/2017)... , Feb. 21, 2017 EMS Find, ... and web based platforms with focus on e-commerce, ... the signing of a worldwide, on-revocable and renewable ... full-service medical transportation company serving healthcare organizations and ... . EpicMD,s platform eliminates the ...
Breaking Medicine Technology:
(Date:2/22/2017)... FALLS, Wis (PRWEB) , ... February 22, 2017 ... ... in a category by itself - the Vector™ Series Multi-Cook Oven offers up ... individual oven chamber, featuring exclusive Structured Air Technology™ for unmatched evenness in cooking. ...
(Date:2/21/2017)... ... February 21, 2017 , ... Tripp ... new hospital-grade power extension cords that meet the most current standards. , The ... edition of the National Fire Protection Association (NFPA) 101 – Life Safety Code ...
(Date:2/21/2017)... ... February 21, 2017 , ... Ray Insurance Agencies, a Dallas area firm providing ... is embarking on a six month charity event aimed at raising local support and ... is one of the deadliest diseases in America; more than 7.5 million people die ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... , ... Along with Valentine’s Day, February marks American Heart Month, a great ... to a lifetime of heart health. In addition, it is a time to ... Athletic Trainers’ Society of New Jersey (ATSNJ) is urging sports programs to prepare comprehensive ...
Breaking Medicine News(10 mins):